TD Private Client Wealth’s Twist Bioscience TWST Stock Holding History

TD Private Client Wealth’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96K	Hold	19	–	–	﹤0.01%	1360
2026 Q1	$903	Sell	19 -15	-44%	-$673	﹤0.01%	1402
2025 Q4	$1.08K	Hold	34	–	–	﹤0.01%	1356
2025 Q3	$957	Buy	+34	New	+$1.03K	﹤0.01%	1339
2024 Q3	–	Sell	-365	Closed	-$18K	–	1298
2024 Q2	$18K	Buy	365 +66	+22%	+$2.69K	﹤0.01%	966
2024 Q1	$10.3K	Sell	299 -135	-31%	-$4.87K	﹤0.01%	1034
2023 Q4	$16K	Buy	434 +135	+45%	+$3.12K	﹤0.01%	984
2023 Q3	$6.06K	Sell	299 -7	-2%	-$154	﹤0.01%	1094
2023 Q2	$6.26K	Hold	306	–	–	﹤0.01%	1108
2023 Q1	$4.61K	Hold	306	–	–	﹤0.01%	1108
2022 Q4	$7.29K	Buy	306 +160	+110%	+$4.64K	﹤0.01%	1046
2022 Q3	$5.14K	Buy	146 +7	+5%	+$297	﹤0.01%	1055
2022 Q2	$4.86K	Buy	+139	New	+$4.92K	﹤0.01%	1072

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

TD Private Client Wealth's TWST Position: Q2 2026 in Review

TD Private Client Wealth held its Twist Bioscience (TWST) position steady in Q2 2026 at 19 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1360.

TD Private Client Wealth first reported a position in TWST in Q2 2022 and has held it in 13 quarters since. The position peaked at $18K in Q2 2024. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

TD Private Client Wealth held 19 shares of Twist Bioscience worth $1.96K as of Q2 2026.
TD Private Client Wealth left its Twist Bioscience share count unchanged in Q2 2026.
Twist Bioscience made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1360 holding.
TD Private Client Wealth first reported a position in Twist Bioscience in Q2 2022 and has held it in 13 quarters since.
TD Private Client Wealth's Twist Bioscience position peaked at $18K in Q2 2024.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.